Burzynski Research Institute, Inc.
OTC: BZYR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Stanislaw R. Burzynski
- Employees
- 1
- Headquarters
- Houston, United States
- IPO year
- 1997
- Market cap
- $788.7K
- Website
- https://propcitweb.ddns.net:83
Loading BZYR…
Loading profile data…Frequently asked questions about BZYR
What does Burzynski Research Institute, Inc. (BZYR) do?
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Anti...
Where does BZYR trade?
Burzynski Research Institute, Inc. (BZYR) trades on the Other OTC.
What sector is BZYR in?
Burzynski Research Institute, Inc. (BZYR) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Burzynski Research Institute, Inc.?
Stanislaw R. Burzynski is the chief executive officer of Burzynski Research Institute, Inc. (BZYR).
Where is Burzynski Research Institute, Inc. headquartered?
Burzynski Research Institute, Inc. is headquartered in United States.
Does BZYR pay a dividend?
Burzynski Research Institute, Inc. (BZYR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BZYR go public?
Burzynski Research Institute, Inc. (BZYR) completed its initial public offering in 1997.